Results 241 to 250 of about 318,932 (267)
Some of the next articles are maybe not open access.
AJN, American Journal of Nursing, 1984
J L, Eddy, R, Selgas-Cordes, M, Curran
openaire +2 more sources
J L, Eddy, R, Selgas-Cordes, M, Curran
openaire +2 more sources
Current Hematologic Malignancy Reports, 2011
Most non-Hodgkin lymphomas (NHL) are of B-cell origin; only about 10% are T-cell or NK-cell lymphomas. The clinical features of T/NK-cell lymphomas differ from those of B-cell lymphomas: advanced stage and extranodal disease are more common and the prognosis is worse.
openaire +3 more sources
Most non-Hodgkin lymphomas (NHL) are of B-cell origin; only about 10% are T-cell or NK-cell lymphomas. The clinical features of T/NK-cell lymphomas differ from those of B-cell lymphomas: advanced stage and extranodal disease are more common and the prognosis is worse.
openaire +3 more sources
Hematology/Oncology Clinics of North America
Cutaneous T-cell lymphoma is a group of non-Hodgkin T-cell lymphomas that develop in and affect the skin but can potentially spread to other organs. There are many subtypes, the most common of which are mycosis fungoides, Sezary syndrome, lymphomatoid papulosis, and primary cutaneous anaplastic large cell lymphoma.
David M, Weiner, Alain H, Rook
openaire +2 more sources
Cutaneous T-cell lymphoma is a group of non-Hodgkin T-cell lymphomas that develop in and affect the skin but can potentially spread to other organs. There are many subtypes, the most common of which are mycosis fungoides, Sezary syndrome, lymphomatoid papulosis, and primary cutaneous anaplastic large cell lymphoma.
David M, Weiner, Alain H, Rook
openaire +2 more sources
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management
Ca-A Cancer Journal for Clinicians, 2020Enrica Marchi
exaly